Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (F31 AI145750, R01 AI051231, P30 AI050409, R01 AI64060)
NIH Office of the Director (OD P51OD11132)
International AIDS Vaccine Initiative (SOW2166)
Received: 21 December 2020
Accepted: 6 March 2021
First Online: 17 March 2021
: This study was approved by the Emory Institutional Review Board, the Rwanda National Ethics Committee and the University of Zambia Research Ethic Committee.All participants gave written informed consent for their enrollment in the cohort.
: Not applicable.
: The authors declare no competing interests.